Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Air and Climate
- Health and Safety
- Manufacturing, Other
- Agriculture
- Environmental
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
- Mining
- Defense
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- Government
- Electronics and Computers
- Soil and Groundwater
- Automobile & Ground Transport
- Banking & Finance / Insurance / Legal
- Retail
- Commercial
- Metal
- Paint
- Plastics & Resins
- Printing
- Communications / Telecom / Datacom
Cell Therapy Suppliers & Manufacturers
239 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
At Revvity, we work with you to expedite the development of gene therapy vectors. ...
based inPiscataway, NEW JERSEY (USA)
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading ...
based inSan Diego, CALIFORNIA (USA)
Resilience is your biomanufacturing innovation partner, leading the pursuit of novel medicines by revolutionizing how they’re made, funded and scaled. The technology of manufacturing complex medicines, like cell and gene therapies, hasn’t kept pace ...
Innovators in immunotherapy, stem cell therapy, and regenerative medicine will find like-minded champions at ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
Astrocytes, also known as Astroglia, belong to the family of glial cells in the human central and peripheral nervous system. They have been shown to have central roles in the maintenance of neuronal metabolism and neurotransmitter synthesis. They ...
based inCambridge, MASSACHUSETTS (USA)
Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient's damaged tissues or organs using their own cells. Please use the links to the right to ...
based inMilpitas, CALIFORNIA (USA)
ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT and other gene editing technologies developed after 12 ...
We are developing gene and cell-based therapies. Gene therapy is addition, alteration or removal of genes within cells and biological tissues to treat diseases. A correcting genetic ...
based inJerusalem, ISRAEL
Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin ...
Islet transplantation is a widely used cell therapy technique which achieves normoglycemia (normal blood glucose levels) in diabetic patients. However, one of the biggest challenges is early islet ...
based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
based inMenlo Park, CALIFORNIA (USA)
Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and ...
Gamma delta T cells represent a new generation of universal cell therapy. The current engineered autologous alpha beta T cell products have shown significant efficacy in ...
based inSouth San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
Cell therapy, a new approach that uses immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. First generation approaches have focused on ...
based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
In-house production facility underpins broad CAR T pipeline. Over the past decade, Celyad Oncology has established expertise in Good Manufacturing Practice (GMP) grade cell therapy manufacturing at our 11,000 sq. ...
based inMadison, WISCONSIN (USA)
BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the ...
based inComberton, UNITED KINGDOM
In 1987, a Cambridge University working group spun out under the name Affinity Chromatography Limited. Through the years, the name and owner changed, including time as Prometic Bioseparations before being sold in late 2019 and subsequently ...
based inHaifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor targets. The design of these novel ...
based inNew Delhi, INDIA
Takara Bio companies provide kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, DSS Takara Bio India Private Ltd. is part of a company that holds ...
Generating robust human embryonic stem cell lines under GMP-grade conditions is critical for the progression of clinical research using ES cells. To help you obtain the highest-quality custom cell line, we will work together to define the exact ...
based inCambridge, MASSACHUSETTS (USA)
Alphageneron Pharmaceuticals is a clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer cells (NK) cell and antibody-based therapies to treat cancer. Our seasoned team of biopharmaceutical executives, ...
Our lead clinical stage natural killer (NK) cell therapy, is an autologous platform technology that activates NK cells to kill cancers expressing a unique membrane form of Heat Shock Protein 70 ...
based inCollege Station, TEXAS (USA)
Since 2009, G-CON has lead the cleanroom industry, fulfilling pharmaceutical and biopharmaceutical needs and embracing new trends. G-CON designs, builds and installs prefabricated cleanroom PODs for a variety of dimensions and purposes, from ...
G-CON Building Solutions provides host facility project management solutions to pharmaceutical and biopharmaceutical clients to simplify customer cleanroom projects and provide project completion in a more timely and cost-efficient manner. ...
